• Breaking Down Barriers in Psychedelic Drug Development

  • Jul 2 2024
  • Duración: 42 m
  • Podcast

Breaking Down Barriers in Psychedelic Drug Development  Por  arte de portada

Breaking Down Barriers in Psychedelic Drug Development

  • Resumen

  • Welcome to episode 052 of Life Sciences 360.

    In this episode, of Life Sciences as we dive into the fascinating world of psychedelic therapeutics with Dr. Sam Clark, the Chief Executive Officer of Terran Biosciences. Dr. Clark shares his journey of founding Terran Biosciences, motivated by the need for better treatment options for psychiatric and neurological disorders. Discover how Terran Biosciences is leveraging a tech company structure to accelerate drug development, utilizing AI in imaging, and pioneering innovative prodrugs.

    Learn about the company’s groundbreaking work in developing psychedelics without hallucinations and their mission to make these therapies affordable and accessible to patients.

    Subscribe for more insightful conversations with leaders in the biotech and life sciences industries!

    Chapters:

    00:00 - Introduction
    00:12 - Dr. Sam Clark's Motivation and Background
    01:00 - Founding Terran Biosciences
    01:35 - Challenges in Psychiatric and Neurological Treatment Development
    02:55 - Innovating with a Tech Company Structure
    03:18 - Use of AI and Drug Development Strategies
    04:18 - Slow Translation of Research to Therapies
    05:50 - Development of New Prodrugs
    07:12 - Explanation of Prodrugs
    08:49 - Terran's Lead Assets for Psychotic Disorders
    10:16 - Creating Long-Acting Prodrugs
    12:16 - Addressing Regulatory Hurdles in Psychedelic Research
    14:20 - Pipeline Overview and Future Plans
    16:13 - Importance of Collaboration in Psychedelic Research
    17:58 - The Rise of Big Pharma Interest in Neuroscience
    20:14 - Addressing Stigma Around Psychedelics
    23:02 - Overcoming Regulatory Challenges
    26:31 - Trends in Psychedelic Funding
    31:48 - Making Medications More Accessible
    37:00 - Impact of Psychedelic Approvals on the Industry
    38:20 - Focus on Patient-Centric Approaches
    41:11 - Final Thoughts and Future Announcements

    Follow Terran Biosciences on LinkedIn and X, and visit their website for the latest updates and announcements.

    -----

    Links:

    - [Terran Biosciences on LinkedIn](https://www.linkedin.com/company/terran/)
    - [Terran Biosciences on X](https://x.com/terranbio)
    - [Dr. Sam Clark on X](https://x.com/neonneurons)
    - [Terran Biosciences Website](https://terranbio.com)
    - [Tera XT Website](https://teraxt.com)


    For more, check out the podcast website - www.lifesciencespod.com

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Breaking Down Barriers in Psychedelic Drug Development

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.